4D Molecular Therapeutics, Inc. (FDMT)

NASDAQ: FDMT · USD

$12.9

+0.91 (+7.6%)· Recorded snapshot

Market cap	711M
Revenue (ttm)	92M
Net income (ttm)	-179.2M
EPS (ttm)	-$2.77
Shares out	55.2M
Volume	1,025,769
Beta	2.74

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 92M
Net income (ttm): -179.2M
EPS (ttm): -$2.77
Market cap: 711M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-43.3

P25 n/aP50 n/aP75 n/a

ROIC-27.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All FDMT indicators

Market & fundamental data

Available fields

204

Groups with data

Currency

USD

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001650648
Company name	4D Molecular Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	35104E100
Earnings date	2026-11-09
Earnings time	bmo
Employees	196
Employees change	-31
Employees growth	-13.66%
Enterprise value	$319.6M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2013
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2020-12-11
Is primary listing	Yes
Is SPAC	No
ISIN number	US35104E1001
Last 10-K release date	2026-03-18
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$711M
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$12.87
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	FDMT
U.S. state	California
Website	https://www.4dmoleculartherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-21.55%
EV/Sales	3.33x
FCF / EV yield	-50.87%
FCF yield	-22.34%
Forward EV/Sales	20.48x
Forward P/S	46.63x
P/B ratio	1.62x
P/S ratio	7.59x
Price / tangible book value	1.71x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-210.76%
EBITDA margin	-205.3%
Gross margin	-157.7%
Operating margin	-210.76%
Pretax margin	-194.74%
Profit margin	-194.74%
Profit per employee	$-914,158
Revenue per employee	$469,429
ROA	-25.09%
ROA (5Y)	-20.62%
ROCE	-43.58%
ROE	-43.25%
ROE (5Y)	-33.63%
ROIC	-27.21%
SBC / revenue	22.18%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Net income growth years	1
Revenue growth	278,712.12%
Revenue growth (Q)	25,106.67%
Revenue growth (QoQ)	24.09%
Revenue growth 3Y	242.75%
Revenue growth 5Y	31.93%
Revenue growth quarters	5
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$106,000
Depreciation and amortization	$5M
EBIT	$-193.9M
EBITDA	$-188.9M
EPS	$-2.77
FCF per share	$-2.82
Financing cash flow	$165.9M
Free cash flow	$-156M
Free cash flow minus SBC	$-176.4M
Gross profit	$-145.1M
Investing cash flow	$-16.6M
Net borrowing	$19.3M
Net cash flow	$-6.8M
Net income	$-179.2M
Operating cash flow minus SBC	$-176.5M
Operating income	$-193.9M
Revenue	$92M
Stock-based compensation	$20.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.4
Book value per share	$7.38
Debt / equity	0.1
Long-term assets	$109.7M
Long-term liabilities	$37.3M
Net cash (debt)	$391.4M
Net cash / market cap	56.08%
Net cash growth	-0.65%
Net debt / equity	-0.96
Piotroski F-Score	2
Property, plant and equipment	$28.9M
Shareholders' equity	$407.7M
Tangible book value	$407.7M
Tangible book value per share	$7.38
Total assets	$492.6M
Total cash	$361.3M
Total debt	$39.2M
Total liabilities	$85M
WACC	18.28%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.19
Current assets	$383M
Current liabilities	$47.7M
Current ratio	8.03
Net working capital	$-20.7M
Quick ratio	7.68
Working capital	$335.3M
Working capital turnover	0.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-15.93%
Dividend yield	0%
Shareholder yield	-15.93%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$11.50
1D price change	7.61%
1M price change	-11.06%
1M total return	-11.06%
1W price change	1.98%
1W total return	1.98%
1Y price change	4.89%
1Y return CAGR	4.89%
1Y total return	4.89%
20-day SMA	$12.54
200-day SMA	$10.83
3M price change	23.99%
3M total return	23.99%
3Y price change	22.92%
3Y return CAGR	7.12%
3Y total return	22.92%
50-day SMA	$13.88
50-day SMA vs 200-day SMA	50over200
52-week high	$16.93
52-week high date	2026-08-19
52-week low	$6.96
52-week low date	2026-01-05
5Y price change	-58.93%
5Y return CAGR	-16.31%
5Y total return	-58.93%
6M price change	36.19%
6M total return	36.19%
All-time high	$55.11
All-time high date	2021-02-11
All-time low	$2.24
All-time low date	2025-04-09
Average true range (ATR)	$0.95
Average volume	1M
Beta (1Y)	1.1
Beta (2Y)	0.75
Beta (5Y)	2.74
Change from 52-week high	-23.98%
Change from 52-week low	84.91%
Change from all-time high	-76.65%
Change from all-time low	475.84%
Change from open	9.63%
Day's gap	-1.84%
Dollar volume	$13.2M
High price	$12.87
Low price	$11.74
Monthly RSI	53.06
Open price	$11.74
Position in 52-week range	100%
Premarket change	3.85%
Premarket close	$11.96
Premarket price	$12.42
Premarket volume	328
Previous close	$11.96
Price vs 150-day SMA	11.92%
Price vs 20-day SMA	2.67%
Price vs 200-day SMA	18.81%
Price vs 50-day SMA	-7.26%
Relative volume	1.01
Return from IPO open	-68.41%
Return from IPO price	-45.07%
RSI	50.62
Sharpe ratio	0.39
Sharpe ratio (3Y)	0.49
Sharpe ratio (5Y)	0.2
Sortino ratio	0.64
Sortino ratio (3Y)	0.9
Sortino ratio (5Y)	0.39
Volume	1M
Weekly RSI	53.39
YTD price change	71.6%
YTD total return	71.6%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	42.6M
Float percentage	77.03%
Shares change (QoQ)	3.24%
Shares change (YoY)	15.93%
Shares held by insiders	2.74%
Shares held by institutions	86.32%
Shares outstanding	55.2M
Short % of float	27.1%
Short % of shares	20.87%
Short ratio	11.6 days

Deeper analysis on FDMT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this FDMT report

Is a complete FDMT research report available?

No complete published report is available for 4D Molecular Therapeutics, Inc. (FDMT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

4D Molecular Therapeutics, Inc. (FDMT)

Price

Financial snapshot

Fair-value bridge

Latest news · FDMT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FDMT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on FDMT

Frequently asked questions